237 related articles for article (PubMed ID: 35507739)
1. Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
Loomes KM; Squires RH; Kelly D; Rajwal S; Soufi N; Lachaux A; Jankowska I; Mack C; Setchell KDR; Karthikeyan P; Kennedy C; Dorenbaum A; Desai NK; Garner W; Jaecklin T; Vig P; Miethke A; Thompson RJ
Hepatol Commun; 2022 Sep; 6(9):2379-2390. PubMed ID: 35507739
[TBL] [Abstract][Full Text] [Related]
2. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Miethke AG; Moukarzel A; Porta G; Covarrubias Esquer J; Czubkowski P; Ordonez F; Mosca A; Aqul AA; Squires RH; Sokal E; D'Agostino D; Baumann U; D'Antiga L; Kasi N; Laborde N; Arikan C; Lin CH; Gilmour S; Mittal N; Chiou FK; Horslen SP; Huber WD; Jaecklin T; Nunes T; Lascau A; Longpre L; Mogul DB; Garner W; Vig P; Hupertz VF; Gonzalez-Peralta RP; Ekong U; Hartley J; Laverdure N; Ovchinsky N; Thompson RJ
Lancet Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38723644
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.
Gonzales E; Hardikar W; Stormon M; Baker A; Hierro L; Gliwicz D; Lacaille F; Lachaux A; Sturm E; Setchell KDR; Kennedy C; Dorenbaum A; Steinmetz J; Desai NK; Wardle AJ; Garner W; Vig P; Jaecklin T; Sokal EM; Jacquemin E
Lancet; 2021 Oct; 398(10311):1581-1592. PubMed ID: 34755627
[TBL] [Abstract][Full Text] [Related]
4. Mutation Analysis and Disease Features at Presentation in a Multi-Center Cohort of Children With Monogenic Cholestasis.
Hertel PM; Bull LN; Thompson RJ; Goodrich NP; Ye W; Magee JC; Squires RH; Bass LM; Heubi JE; Kim GE; Ranganathan S; Schwarz KB; Bozic MA; Horslen SP; Clifton MS; Turmelle YP; Suchy FJ; Superina RA; Wang KS; Loomes KM; Kamath BM; Sokol RJ; Shneider BL;
J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):169-177. PubMed ID: 34016879
[TBL] [Abstract][Full Text] [Related]
5. Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency.
Zhao X; Zhang W; Vig P; Kostrub C; Setchell KDR
Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295854
[TBL] [Abstract][Full Text] [Related]
6. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
[TBL] [Abstract][Full Text] [Related]
7. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.
Bull LN; Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Dodge JL; Emerick K; Wanty C; Wali S; Blanchard S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Houwen R; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Sokal E; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ
Hepatol Commun; 2018 May; 2(5):515-528. PubMed ID: 29761168
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.
Masahata K; Ueno T; Bessho K; Kodama T; Tsukada R; Saka R; Tazuke Y; Miyagawa S; Okuyama H
Surg Case Rep; 2022 Jan; 8(1):10. PubMed ID: 35024979
[TBL] [Abstract][Full Text] [Related]
11. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
12. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
Bowlus CL; Eksteen B; Cheung AC; Thorburn D; Moylan CA; Pockros PJ; Forman LM; Dorenbaum A; Hirschfield GM; Kennedy C; Jaecklin T; McKibben A; Chien E; Baek M; Vig P; Levy C
Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37184523
[TBL] [Abstract][Full Text] [Related]
14. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
15. Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.
van Wessel DBE; Thompson RJ; Gonzales E; Jankowska I; Shneider BL; Sokal E; Grammatikopoulos T; Kadaristiana A; Jacquemin E; Spraul A; Lipiński P; Czubkowski P; Rock N; Shagrani M; Broering D; Algoufi T; Mazhar N; Nicastro E; Kelly D; Nebbia G; Arnell H; Fischler B; Hulscher JBF; Serranti D; Arikan C; Debray D; Lacaille F; Goncalves C; Hierro L; Muñoz Bartolo G; Mozer-Glassberg Y; Azaz A; Brecelj J; Dezsőfi A; Luigi Calvo P; Krebs-Schmitt D; Hartleif S; van der Woerd WL; Wang JS; Li LT; Durmaz Ö; Kerkar N; Hørby Jørgensen M; Fischer R; Jimenez-Rivera C; Alam S; Cananzi M; Laverdure N; Targa Ferreira C; Ordonez F; Wang H; Sency V; Mo Kim K; Chen HL; Carvalho E; Fabre A; Quintero Bernabeu J; Alonso EM; Sokol RJ; Suchy FJ; Loomes KM; McKiernan PJ; Rosenthal P; Turmelle Y; Rao GS; Horslen S; Kamath BM; Rogalidou M; Karnsakul WW; Hansen B; Verkade HJ;
Hepatology; 2021 Aug; 74(2):892-906. PubMed ID: 33666275
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after cholecystocolostomy for progressive familial intrahepatic cholestasis.
Chen L; Xiao H; Ren XH; Li L
Hepatol Res; 2018 Dec; 48(13):1163-1171. PubMed ID: 29934967
[TBL] [Abstract][Full Text] [Related]
17. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
Thompson RJ; Arnell H; Artan R; Baumann U; Calvo PL; Czubkowski P; Dalgic B; D'Antiga L; Durmaz Ö; Fischler B; Gonzalès E; Grammatikopoulos T; Gupte G; Hardikar W; Houwen RHJ; Kamath BM; Karpen SJ; Kjems L; Lacaille F; Lachaux A; Lainka E; Mack CL; Mattsson JP; McKiernan P; Özen H; Rajwal SR; Roquelaure B; Shagrani M; Shteyer E; Soufi N; Sturm E; Tessier ME; Verkade HJ; Horn P
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):830-842. PubMed ID: 35780807
[TBL] [Abstract][Full Text] [Related]
18. Progressive familial intrahepatic cholestasis: a personal perspective.
Knisely AS
Pediatr Dev Pathol; 2000; 3(2):113-25. PubMed ID: 10679031
[TBL] [Abstract][Full Text] [Related]
19. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
20. Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2.
Varma S; Revencu N; Stephenne X; Scheers I; Smets F; Beleza-Meireles A; Reding R; Roskams T; Sokal EM
Hepatology; 2015 Jul; 62(1):198-206. PubMed ID: 25847299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
